Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.22
OMI's Cash to Debt is ranked lower than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.59 vs. OMI: 0.22 )
Ranked among companies with meaningful Cash to Debt only.
OMI' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.08 Max: 1.06
Current: 0.22
0
1.06
Equity to Asset 0.36
OMI's Equity to Asset is ranked lower than
64% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. OMI: 0.36 )
Ranked among companies with meaningful Equity to Asset only.
OMI' s Equity to Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.38 Max: 0.49
Current: 0.36
0.2
0.49
Interest Coverage 13.51
OMI's Interest Coverage is ranked higher than
53% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.22 vs. OMI: 13.51 )
Ranked among companies with meaningful Interest Coverage only.
OMI' s Interest Coverage Range Over the Past 10 Years
Min: 6.23  Med: 12.49 Max: 15.45
Current: 13.51
6.23
15.45
F-Score: 6
Z-Score: 5.23
M-Score: -2.23
WACC vs ROIC
8.26%
7.28%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.87
OMI's Operating margin (%) is ranked lower than
72% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.96 vs. OMI: 1.87 )
Ranked among companies with meaningful Operating margin (%) only.
OMI' s Operating margin (%) Range Over the Past 10 Years
Min: 1.69  Med: 2.29 Max: 2.5
Current: 1.87
1.69
2.5
Net-margin (%) 0.87
OMI's Net-margin (%) is ranked lower than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. OMI: 0.87 )
Ranked among companies with meaningful Net-margin (%) only.
OMI' s Net-margin (%) Range Over the Past 10 Years
Min: 0.7  Med: 1.26 Max: 1.36
Current: 0.87
0.7
1.36
ROE (%) 8.56
OMI's ROE (%) is ranked lower than
60% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.53 vs. OMI: 8.56 )
Ranked among companies with meaningful ROE (%) only.
OMI' s ROE (%) Range Over the Past 10 Years
Min: 6.54  Med: 12.75 Max: 14.35
Current: 8.56
6.54
14.35
ROA (%) 3.06
OMI's ROA (%) is ranked lower than
63% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.86 vs. OMI: 3.06 )
Ranked among companies with meaningful ROA (%) only.
OMI' s ROA (%) Range Over the Past 10 Years
Min: 2.63  Med: 5.34 Max: 6.2
Current: 3.06
2.63
6.2
ROC (Joel Greenblatt) (%) 19.92
OMI's ROC (Joel Greenblatt) (%) is ranked lower than
60% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.26 vs. OMI: 19.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 17.08  Med: 26.39 Max: 30.56
Current: 19.92
17.08
30.56
Revenue Growth (3Y)(%) 3.40
OMI's Revenue Growth (3Y)(%) is ranked lower than
60% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. OMI: 3.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.5  Med: 4.30 Max: 13.5
Current: 3.4
-0.5
13.5
EBITDA Growth (3Y)(%) -1.80
OMI's EBITDA Growth (3Y)(%) is ranked lower than
74% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. OMI: -1.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.8  Med: 5.85 Max: 22.8
Current: -1.8
-1.8
22.8
EPS Growth (3Y)(%) -16.70
OMI's EPS Growth (3Y)(%) is ranked lower than
88% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. OMI: -16.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -16.7  Med: 14.15 Max: 49.4
Current: -16.7
-16.7
49.4
» OMI's 10-Y Financials

Financials (Next Earnings Date: 2016-02-09)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

OMI Guru Trades in Q1 2015

James Barrow 115,387 sh (New)
Jim Simons 163,450 sh (+70.70%)
Richard Pzena 1,077,426 sh (+20.54%)
Paul Tudor Jones 27,000 sh (+13.57%)
Pioneer Investments 596,631 sh (+0.57%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli 203,650 sh (-2.20%)
John Keeley 35,015 sh (-2.51%)
Chuck Royce 1,594,250 sh (-5.28%)
David Dreman 234,729 sh (-13.83%)
» More
Q2 2015

OMI Guru Trades in Q2 2015

Charles Brandes 15,190 sh (New)
Joel Greenblatt 38,139 sh (New)
Steven Cohen 800 sh (New)
Jim Simons 375,750 sh (+129.89%)
James Barrow 149,712 sh (+29.75%)
John Keeley 38,160 sh (+8.98%)
David Dreman 255,564 sh (+8.88%)
Paul Tudor Jones 27,400 sh (+1.48%)
Richard Pzena 1,087,551 sh (+0.94%)
Pioneer Investments 598,149 sh (+0.25%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Mario Gabelli 193,650 sh (-4.91%)
Chuck Royce 1,475,150 sh (-7.47%)
» More
Q3 2015

OMI Guru Trades in Q3 2015

John Hussman 4,000 sh (New)
Joel Greenblatt 1,152,390 sh (+2921.55%)
Paul Tudor Jones 250,000 sh (+812.41%)
John Keeley 52,725 sh (+38.17%)
David Dreman 290,760 sh (+13.77%)
Pioneer Investments 599,460 sh (+0.22%)
Charles Brandes 15,190 sh (unchged)
Mario Gabelli 193,650 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
James Barrow 149,712 sh (unchged)
Steven Cohen Sold Out
Richard Pzena 1,037,426 sh (-4.61%)
Chuck Royce 1,372,150 sh (-6.98%)
Jim Simons 28,450 sh (-92.43%)
» More
Q4 2015

OMI Guru Trades in Q4 2015

James Barrow 152,574 sh (+1.91%)
Mario Gabelli 193,650 sh (unchged)
John Hussman Sold Out
Vanguard Health Care Fund Sold Out
Richard Pzena 1,029,003 sh (-0.81%)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.30
OMI's P/E(ttm) is ranked lower than
73% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.31 vs. OMI: 25.30 )
Ranked among companies with meaningful P/E(ttm) only.
OMI' s P/E(ttm) Range Over the Past 10 Years
Min: 13.55  Med: 19.68 Max: 36.19
Current: 25.3
13.55
36.19
Forward P/E 15.60
OMI's Forward P/E is ranked lower than
59% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.66 vs. OMI: 15.60 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.20
OMI's PE(NRI) is ranked lower than
57% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.33 vs. OMI: 25.20 )
Ranked among companies with meaningful PE(NRI) only.
OMI' s PE(NRI) Range Over the Past 10 Years
Min: 13.47  Med: 19.38 Max: 35.63
Current: 25.2
13.47
35.63
P/B 2.19
OMI's P/B is ranked lower than
63% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.96 vs. OMI: 2.19 )
Ranked among companies with meaningful P/B only.
OMI' s P/B Range Over the Past 10 Years
Min: 1.79  Med: 2.26 Max: 3.1
Current: 2.19
1.79
3.1
P/S 0.22
OMI's P/S is ranked higher than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. OMI: 0.22 )
Ranked among companies with meaningful P/S only.
OMI' s P/S Range Over the Past 10 Years
Min: 0.18  Med: 0.23 Max: 0.29
Current: 0.22
0.18
0.29
PFCF 29.80
OMI's PFCF is ranked lower than
86% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.70 vs. OMI: 29.80 )
Ranked among companies with meaningful PFCF only.
OMI' s PFCF Range Over the Past 10 Years
Min: 5.38  Med: 18.72 Max: 2217
Current: 29.8
5.38
2217
POCF 17.76
OMI's POCF is ranked lower than
58% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.65 vs. OMI: 17.76 )
Ranked among companies with meaningful POCF only.
OMI' s POCF Range Over the Past 10 Years
Min: 4.92  Med: 14.41 Max: 63.05
Current: 17.76
4.92
63.05
EV-to-EBIT 14.21
OMI's EV-to-EBIT is ranked lower than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.83 vs. OMI: 14.21 )
Ranked among companies with meaningful EV-to-EBIT only.
OMI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8  Med: 11.30 Max: 22.8
Current: 14.21
8
22.8
EV-to-EBITDA 10.14
OMI's EV-to-EBITDA is ranked higher than
68% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.14 vs. OMI: 10.14 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 9.60 Max: 16.4
Current: 10.14
7.1
16.4
PEG 42.00
OMI's PEG is ranked lower than
100% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. OMI: 42.00 )
Ranked among companies with meaningful PEG only.
OMI' s PEG Range Over the Past 10 Years
Min: 0.92  Med: 2.94 Max: 160.19
Current: 42
0.92
160.19
Shiller P/E 21.75
OMI's Shiller P/E is ranked higher than
79% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.06 vs. OMI: 21.75 )
Ranked among companies with meaningful Shiller P/E only.
OMI' s Shiller P/E Range Over the Past 10 Years
Min: 18.5  Med: 23.96 Max: 34.4
Current: 21.75
18.5
34.4
Current Ratio 1.81
OMI's Current Ratio is ranked higher than
63% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.56 vs. OMI: 1.81 )
Ranked among companies with meaningful Current Ratio only.
OMI' s Current Ratio Range Over the Past 10 Years
Min: 1.55  Med: 1.83 Max: 2.17
Current: 1.81
1.55
2.17
Quick Ratio 0.97
OMI's Quick Ratio is ranked lower than
65% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. OMI: 0.97 )
Ranked among companies with meaningful Quick Ratio only.
OMI' s Quick Ratio Range Over the Past 10 Years
Min: 0.6  Med: 0.93 Max: 1.17
Current: 0.97
0.6
1.17
Days Inventory 37.37
OMI's Days Inventory is ranked higher than
60% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 50.17 vs. OMI: 37.37 )
Ranked among companies with meaningful Days Inventory only.
OMI' s Days Inventory Range Over the Past 10 Years
Min: 34.59  Med: 35.96 Max: 40.9
Current: 37.37
34.59
40.9
Days Sales Outstanding 23.92
OMI's Days Sales Outstanding is ranked higher than
87% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.51 vs. OMI: 23.92 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.19  Med: 23.63 Max: 35.56
Current: 23.92
21.19
35.56
Days Payable 29.43
OMI's Days Payable is ranked lower than
88% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.19 vs. OMI: 29.43 )
Ranked among companies with meaningful Days Payable only.
OMI' s Days Payable Range Over the Past 10 Years
Min: 26.53  Med: 27.93 Max: 40.11
Current: 29.43
26.53
40.11

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.95
OMI's Dividend Yield is ranked higher than
76% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.89 vs. OMI: 2.95 )
Ranked among companies with meaningful Dividend Yield only.
OMI' s Dividend Yield Range Over the Past 10 Years
Min: 1.47  Med: 2.32 Max: 3.19
Current: 2.95
1.47
3.19
Dividend Payout 0.74
OMI's Dividend Payout is ranked lower than
69% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.34 vs. OMI: 0.74 )
Ranked among companies with meaningful Dividend Payout only.
OMI' s Dividend Payout Range Over the Past 10 Years
Min: 0.21  Med: 0.34 Max: 4.29
Current: 0.74
0.21
4.29
Dividend Growth (3y) 7.70
OMI's Dividend Growth (3y) is ranked lower than
76% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.60 vs. OMI: 7.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
OMI' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 7.7  Med: 13.65 Max: 19.7
Current: 7.7
7.7
19.7
Forward Dividend Yield 2.95
OMI's Forward Dividend Yield is ranked higher than
72% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.07 vs. OMI: 2.95 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 4.85
OMI's Yield on cost (5-Year) is ranked higher than
66% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.23 vs. OMI: 4.85 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OMI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 2.41  Med: 3.80 Max: 5.23
Current: 4.85
2.41
5.23
3-Year Average Share Buyback Ratio 0.40
OMI's 3-Year Average Share Buyback Ratio is ranked higher than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.80 vs. OMI: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.3  Med: -1.15 Max: 0.4
Current: 0.4
-5.3
0.4

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 13.23
OMI's Price/Net Current Asset Value is ranked lower than
79% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.80 vs. OMI: 13.23 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
OMI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.55  Med: 5.88 Max: 106.43
Current: 13.23
3.55
106.43
Price/Tangible Book 4.62
OMI's Price/Tangible Book is ranked lower than
63% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.54 vs. OMI: 4.62 )
Ranked among companies with meaningful Price/Tangible Book only.
OMI' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.72  Med: 4.39 Max: 175
Current: 4.62
2.72
175
Price/Projected FCF 1.36
OMI's Price/Projected FCF is ranked lower than
58% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.26 vs. OMI: 1.36 )
Ranked among companies with meaningful Price/Projected FCF only.
OMI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.38 Max: 2.72
Current: 1.36
0.84
2.72
Price/Median PS Value 0.94
OMI's Price/Median PS Value is ranked higher than
56% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. OMI: 0.94 )
Ranked among companies with meaningful Price/Median PS Value only.
OMI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.37  Med: 0.95 Max: 1.21
Current: 0.94
0.37
1.21
Price/Graham Number 2.27
OMI's Price/Graham Number is ranked lower than
59% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.52 vs. OMI: 2.27 )
Ranked among companies with meaningful Price/Graham Number only.
OMI' s Price/Graham Number Range Over the Past 10 Years
Min: 1.36  Med: 1.90 Max: 15
Current: 2.27
1.36
15
Earnings Yield (Greenblatt) (%) 7.00
OMI's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.10 vs. OMI: 7.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.4  Med: 8.80 Max: 12.4
Current: 7
4.4
12.4
Forward Rate of Return (Yacktman) (%) 3.59
OMI's Forward Rate of Return (Yacktman) (%) is ranked lower than
72% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.60 vs. OMI: 3.59 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 2.8  Med: 9.90 Max: 20
Current: 3.59
2.8
20

More Statistics

Revenue(Mil) $9777
EPS $ 1.36
Beta1.06
Short Percentage of Float15.18%
52-Week Range $31.89 - 39.29
Shares Outstanding(Mil)62.89

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 9,793 10,023 10,221
EPS($) 1.91 2.04 2.20
EPS without NRI($) 1.91 2.04 2.20

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:6OM.Germany,
Owens & Minor Inc was founded in 1882 and incorporated in 1926 in Richmond, Virginia. The Company is a healthcare logistics company that connects the world of medical products to the point of care. It provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company on August 31, 2012, acquired the Movianto Group (Movianto), an established European healthcare third-party logistics provider. The Company's domestic segment includes all functions in the United States relating to Company's role as a healthcare services company providing distribution and logistics services to healthcare providers and manufacturers. The International segment consists of Movianto, Company's European third-party logistics service. The Company's competitors are Cardinal Health, Inc. and privately-held Medline, Inc. The Domestic segment had 43 distribution centers as well as office and warehouse space across the United States. The International segment leases18 and owns two logistics centers across 11 European countries. The Company provides distribution, outsourced resource management and/or consulting services to thousands of healthcare provider customers which include multi-facility networks of healthcare providers offering a broad spectrum of healthcare services to a particular market or markets (IHNs) as well as smaller, independent hospitals in the United States. The medical/surgical supply distribution industry is subject to regulation by federal, state and local government agencies.
» More Articles for OMI

Headlines

Articles On GuruFocus.com
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Guru-Held Stocks Near Historical Low P/S Oct 03 2014 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Trading Near Historical Low P/S Ratios Jul 18 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Jun 04 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 20 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 

More From Other Websites
Owens & Minor Plans to Release 4th Quarter & Full-Year 2015 Financial Results on Monday, February 8,... Jan 27 2016
Owens & Minor Plans to Release 4th Quarter & Full-Year 2015 Financial Results on Monday, February 8,... Jan 27 2016
OWENS & MINOR INC/VA/ Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change... Jan 06 2016
Owens & Minor to Participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday,... Jan 06 2016
Owens & Minor to Participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday,... Jan 06 2016
Owens & Minor, Inc. breached its 50 day moving average in a Bullish Manner : December 29, 2015 Dec 29 2015
Owens & Minor, Inc. breached its 50 day moving average in a Bearish Manner : December 10, 2015 Dec 10 2015
OWENS & MINOR INC/VA/ Financials Dec 08 2015
OWENS & MINOR INC/VA/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 04 2015
Owens & Minor Issues Financial Outlook for 2016 at Annual Investor Meeting Dec 04 2015
Owens & Minor Issues Financial Outlook for 2016 at Annual Investor Meeting Dec 04 2015
Owens & Minor Earns No. 4 Ranking on the Gartner 2015 Healthcare Supply Chain Top 25 Dec 02 2015
Owens & Minor Earns No. 4 Ranking on the Gartner 2015 Healthcare Supply Chain Top 25 Dec 02 2015
Is WESCO International, Inc. (WCC) A Good Stock To Buy? Nov 29 2015
Here is How Hedge Funds Are Trading Owens & Minor, Inc. (OMI) Nov 23 2015
Zacks Investment Ideas feature highlights: Berry Plastics, Leidos Holdings, Nvidia, Home Depot and... Nov 19 2015
3 Reasons Momentum Stock Investors Will Love Owens & Minor (OMI) Nov 19 2015
5 Easy Money Stocks to Buy Nov 18 2015
Owens & Minor Recognizes Outstanding Manufacturers at 2015 National Sales Conference Nov 13 2015
Owens & Minor Recognizes Outstanding Manufacturers at 2015 National Sales Conference Nov 13 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK